Literature DB >> 7597444

Epidemiology of hepatitis C in the West.

M J Alter1.   

Abstract

Most hepatitis C occurs among young adults with high-risk behaviors or lifestyles. Although the most efficient transmission of HCV is through large or repeated percutaneous exposures to infectious blood, transmission also seems to occur through occupational exposure, sexual activity, household contact, and perinatal exposure. The risk of transmission in these settings is most likely dependent on the titer of virus as well as the type and size of the inoculum and the route of transmission. The apparent inconsistency of results between studies is probably a result of the small sample sizes, in that insufficient numbers of infectious persons are included, as well as the variations in methodology and serologic testing. Although HCV may be inefficiently transmitted by inapparent parenteral or mucosal exposures, the high rate of persistent infection with HCV creates a large reservoir of persons who are infectious to others. Current preventive measures, such as donor screening, prevent only a small proportion of the disease. Epidemiologic studies to define the risk of, and the factors facilitating transmission of HCV in other settings, still need to be conducted to develop measures to prevent most disease acquisition.

Entities:  

Mesh:

Year:  1995        PMID: 7597444     DOI: 10.1055/s-2007-1007259

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  82 in total

1.  Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection.

Authors:  H M Diepolder; J T Gerlach; R Zachoval; R M Hoffmann; M C Jung; E A Wierenga; S Scholz; T Santantonio; M Houghton; S Southwood; A Sette; G R Pape
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 2.  Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights.

Authors:  Gül Bahtiyar; John J Shin; Ayse Aytaman; James R Sowers; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

3.  Prevalence of HCV infection among health care workers in a hospital in central Italy.

Authors:  C Catalani; A Biggeri; A Gottard; M Benvenuti; E Frati; C Cecchini
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

4.  Seroprevalence of hepatitis C virus in rural population of Bangladesh.

Authors:  Mobin Khan; M Golam Mustafa; Nooruddin Ahmad; M Shahinul Alam; Rahat Hasan Baig; Ziaur Rahman Chowdhry; Mostaq Ahmed
Journal:  Indian J Gastroenterol       Date:  2010-01

Review 5.  Hepatitis C virus infection in the elderly. Epidemiology, prophylaxis and optimal treatment.

Authors:  J Hayashi; S Kashiwagi
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

Review 6.  Molecular biology of hepatitis C virus.

Authors:  Tetsuro Suzuki; Hideki Aizaki; Kyoko Murakami; Ikuo Shoji; Takaji Wakita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

7.  A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment.

Authors:  Amira Pierucci-Lagha; Jonathan Covault; Herbert L Bonkovsky; Richard Feinn; Christine Abreu; Richard K Sterling; Robert J Fontana; Henry R Kranzler
Journal:  Psychosomatics       Date:  2010 Mar-Apr       Impact factor: 2.386

8.  Predictors and noninvasive identification of severe liver fibrosis in patients with chronic hepatitis C.

Authors:  Mohamed A Metwally; Claudia O Zein; Nizar N Zein
Journal:  Dig Dis Sci       Date:  2007-01-09       Impact factor: 3.199

9.  Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients.

Authors:  H Hinrichsen; G Leimenstoll; G Stegen; H Schrader; U R Fölsch; W E Schmidt
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 10.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.